Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Copper-dependent and zinc-dependent enzymes represent a broad class of metalloenzymes that utilize copper or zinc ions as essential cofactors for catalytic activity, structural stability, or both. Copper-dependent enzymes, such as cytochrome c oxidase, tyrosinase, and lysyl oxidase, are critical for cellular respiration, melanin synthesis, and the cross-linking of collagen and elastin. Zinc-dependent enzymes, which constitute one of the largest classes of enzymes, include carbonic anhydrases, matrix metalloproteinases (MMPs), and histone deacetylases (HDACs), performing roles in pH regulation, tissue remodeling, and epigenetic control. A notable example of an enzyme requiring both metals is superoxide dismutase 1 (SOD1), which provides vital antioxidant defense by neutralizing superoxide radicals. Dysregulation of these enzymes or their metal homeostasis is implicated in numerous diseases, including Wilson's disease, Menkes disease, cancer, and neurodegenerative conditions like amyotrophic lateral sclerosis (ALS). Therapeutic interventions often target these enzymes through specific inhibitors, such as ACE inhibitors for hypertension or HDAC inhibitors for cancer, or through chelating agents that modulate metal availability. Monitoring serum metal levels and specific enzymatic activity is essential for assessing treatment efficacy and managing potential toxicities related to metal deficiency.
Inhibition of enzymatic activity through metal chelation, competitive binding at the active site, or allosteric modulation.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copper-dependent and zinc-dependent enzymes.